Search research articles
Contact Us
Filters
Showing results (21-30 of 121) with videos related to
Page
of 13
Sort By:
The Journal of Clinical Investigation
|
July 28, 2015
Therapeutic cancer vaccines
Cornelis J M Melief, Thorbald van Hall, Ramon Arens, et al.
Seminars in Immunology
|
May 28, 2013
Prospects of combinatorial synthetic peptide vaccine-based immunotherapy against cancer
Ramon Arens, Thorbald van Hall, Sjoerd H van der Burg, et al.
Trends in Immunology
|
April 1, 2020
Immunotherapeutic Potential of TGF-β Inhibition and Oncolytic Viruses
Christianne Groeneveldt, Thorbald van Hall, Sjoerd H van der Burg, et al.
Cancer Research
|
October 1, 2009
Design of agonistic altered peptides for the robust induction of CTL directed towards H-2Db in complex with the melanoma-associated epitope gp100
Marianne J B van Stipdonk, Daniel Badia-Martinez, Marjolein Sluijter, et al.
Molecular Immunology
|
July 2, 2014
Dominant contribution of the proteasome and metalloproteinases to TAP-independent MHC-I peptide repertoire
Cláudia C Oliveira, Marjolein Sluijter, Bianca Querido, et al.
European Journal of Immunology
|
September 8, 2011
Peptide transporter TAP mediates between competing antigen sources generating distinct surface MHC class I peptide repertoires
Cláudia C Oliveira, Bianca Querido, Marjolein Sluijter, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 14, 2022
A Single-Domain TCR-like Antibody Selective for the Qa-1<sup>b</sup>/Qdm Peptide Complex Enhances Tumoricidal Activity of NK Cells via Blocking the NKG2A Immune Checkpoint
Soroush Ghaffari, Katherine Upchurch-Ange, Susanne Gimlin, et al.
Journal for Immunotherapy of Cancer
|
October 29, 2023
Longitudinal evaluation of the biodistribution and cellular internalization of the bispecific CD3xTRP1 antibody in syngeneic mouse tumor models
Gerwin Gerhard Wemke Sandker, Jim Middelburg, Evienne Wilbrink, et al.
Cancer Genetics and Cytogenetics
|
January 29, 2003
Application of multicolor fluorescence in situ hybridization analysis for detection of cross-contamination and in vitro progression in commonly used murine tumor cell lines
Joop Wiegant, Thorbald van Hall, Marja van der Burg, et al.
Oncoimmunology
|
May 17, 2017
PD-L1 expression on malignant cells is no prerequisite for checkpoint therapy
Jan Willem Kleinovink, Koen A Marijt, Mark J A Schoonderwoerd, et al.
Page
of 13
Search research articles
Search
Showing results (21-30 of 121) with videos related to
Sort By:
Page
of 13
The Journal of Clinical Investigation
|
July 28, 2015
Therapeutic cancer vaccines
Cornelis J M Melief, Thorbald van Hall, Ramon Arens, et al.
Seminars in Immunology
|
May 28, 2013
Prospects of combinatorial synthetic peptide vaccine-based immunotherapy against cancer
Ramon Arens, Thorbald van Hall, Sjoerd H van der Burg, et al.
Trends in Immunology
|
April 1, 2020
Immunotherapeutic Potential of TGF-β Inhibition and Oncolytic Viruses
Christianne Groeneveldt, Thorbald van Hall, Sjoerd H van der Burg, et al.
Cancer Research
|
October 1, 2009
Design of agonistic altered peptides for the robust induction of CTL directed towards H-2Db in complex with the melanoma-associated epitope gp100
Marianne J B van Stipdonk, Daniel Badia-Martinez, Marjolein Sluijter, et al.
Molecular Immunology
|
July 2, 2014
Dominant contribution of the proteasome and metalloproteinases to TAP-independent MHC-I peptide repertoire
Cláudia C Oliveira, Marjolein Sluijter, Bianca Querido, et al.
European Journal of Immunology
|
September 8, 2011
Peptide transporter TAP mediates between competing antigen sources generating distinct surface MHC class I peptide repertoires
Cláudia C Oliveira, Bianca Querido, Marjolein Sluijter, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 14, 2022
A Single-Domain TCR-like Antibody Selective for the Qa-1<sup>b</sup>/Qdm Peptide Complex Enhances Tumoricidal Activity of NK Cells via Blocking the NKG2A Immune Checkpoint
Soroush Ghaffari, Katherine Upchurch-Ange, Susanne Gimlin, et al.
Journal for Immunotherapy of Cancer
|
October 29, 2023
Longitudinal evaluation of the biodistribution and cellular internalization of the bispecific CD3xTRP1 antibody in syngeneic mouse tumor models
Gerwin Gerhard Wemke Sandker, Jim Middelburg, Evienne Wilbrink, et al.
Cancer Genetics and Cytogenetics
|
January 29, 2003
Application of multicolor fluorescence in situ hybridization analysis for detection of cross-contamination and in vitro progression in commonly used murine tumor cell lines
Joop Wiegant, Thorbald van Hall, Marja van der Burg, et al.
Oncoimmunology
|
May 17, 2017
PD-L1 expression on malignant cells is no prerequisite for checkpoint therapy
Jan Willem Kleinovink, Koen A Marijt, Mark J A Schoonderwoerd, et al.
Page
of 13